Logotipo del repositorio
Comunidades y Colecciones
Estadísticas
Cosmosnew
  1. Inicio
  2. Producción Científica UPeU
  3. Publicaciones
  4. The impact of the COVID-19 pandemic on HIV testing in Peru: an interrupted time series analysis from 2014 to 2022
Cargando...
Miniatura

The impact of the COVID-19 pandemic on HIV testing in Peru: an interrupted time series analysis from 2014 to 2022

Author(s)
Yrene-Cubas, Robinson A.
Universidad Científica del Sur
Pérez-Castilla, Jesus
National University of Saint Anthony the Abbot in Cuzco
Reynaga-Cottle, Daniel E.
Universidad de San Martín de Porres
Bringas, Maria José
Universidad de San Martín de Porres
Soriano Moreno, David  
Universidad Peruana Unión  
Fernandez-Guzman, Daniel
Universidad Científica del Sur
Gonzales-Zamora, Jose
University of Miami
Date Issued
7 de enero de 2025
Type
Article
Publisher
BioMed Central Ltd
Volume
25
Issue
1
Series/Report No.
BMC Infectious Diseases
Contained in
BMC Infectious Diseases
DOI
10.1186/s12879-024-10407-y
ISSN
1471-2334
Abstract
Objectives Our objective was to evaluate the impact of COVID-19 on the proportion of past-year HIV testing in Peru. Methods Utilizing data from the National Demographic and Health Survey of Peru from 2014 to 2022, we conducted an interrupted time series analysis. The proportion of past-year HIV testing per quarter of each year was considered our unit of analysis. Statistical analysis involved segmented regression with Newey-West standard errors, dividing each year of evaluation into four quarters. Additionally, we applied an Autoregressive Integrated Moving Average (ARIMA) model. Results We included 211,359 participants aged 15 to 49 years. The proportion of past-year HIV testing in Peru showed a mean decrease of 8.33% (95%CI: -10.73% to -5.93%) after the COVID-19 lockdown (from August-2020) compared to the previous period (before March-2020). Prior to lockdown, there was a mean quarterly increase of 0.30% (95%CI: 0.21-0.40%) in testing proportion, while after the lockdown, there was a mean quarterly decrease of -0.24% (95%CI: -0.56-0.09%). HIV testing declined in 23 of the 25 regions, ranging from - 23.7% to -3.0%, except in Amazonas and Cajamarca, where increases of 5.3% and 6.8% were observed. Predictions of counterfactual values without the pandemic using the ARIMA model revealed a percentage drop of -9.20% (95%CI: -13.70 to -4.80) in observed compared to predicted values. Conclusions This study highlights the decrease in proportion of past-year HIV testing in Peru following the COVID-19 lockdown, emphasizing the urgent need for targeted interventions to address disparities and ensure equitable access to testing services.
Keywords

Peru

Hiv Testing

Interrupted Time Seri...

Sociodemographic Disp...

Covid-19 Impact

Metrics
Red de relaciones
PersonasOrganizacionesProyectosFinanciamientosProducción científicaPatentesProductosEventosEquipamientoInstalacionesServiciosCVTitulacionesMedicionesIndicadoresDatos
PersonasOrganizacionesProyectosFinanciamientosProducción científicaPatentesProductosEventosEquipamientoInstalacionesServiciosCVTitulacionesMedicionesIndicadoresDatos
Universidad Peruana Unión

CRIS UPeU integra y gestiona la producción científica, investigadores, proyectos, financiamientos, patentes y resultados de I+D+i de la Universidad Peruana Unión, e interopera con PerúCRIS (CONCYTEC) mediante el estándar CERIF · OpenAIRE.

Interopera con PerúCRISCERIF · OpenAIRE

Contacto

  • Carretera Central km 19
  • Ñaña, Lima, Perú
  • +51 998 801 168
  • repositorio@upeu.edu.pe

Horario de atención

  • Lunes a Jueves8:00–12:30 · 14:00–18:00
  • Viernes8:00–13:00
CampusLima · Juliaca · Tarapoto

Interoperabilidad CRIS

  • PerúCRIS
  • Directrices PerúCRIS
  • Modelo CERIF (euroCRIS)
  • CONCYTEC
  • Portal UPeU

footer.built-with footer.link.dspace-cris footer.extension-by footer.link.4science· Diseño por SciBack

  • Accessibility settings
  • Política de privacidad
  • Acuerdo de usuario final